-
Archives
- June 2018
- February 2018
- May 2017
- January 2017
- December 2016
- November 2016
- October 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- August 2015
- July 2015
- June 2015
- March 2015
- February 2015
- September 2014
- July 2014
- January 2014
- November 2013
- July 2013
- June 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- June 2012
- May 2012
- March 2012
- December 2011
- November 2011
- July 2011
- March 2011
-
Meta
Category Archives: Other News
BREXIT: What does it mean for the Life Sciences?
The life sciences industry is critically important to the UK economy: it has a £64 billion turnover and employs more than 233,000 scientists and staff across the UK. It is also one of the most highly regulated and globally harmonised … Continue reading
Comments Off on BREXIT: What does it mean for the Life Sciences?
Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines
ITMAT in Edinburgh Big Data & the Development of New Medicines Friday 17 March 2017, Edinburgh, UK Registration and abstract submission are open for the Institute for Translational Medicine & Therapeutics (ITMAT) in Edinburgh Meeting, which will be held on ‘Big Data & … Continue reading
Comments Off on Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines
Big Data & the Development of New Medicines
ITMAT in Edinburgh Big Data & the Development of New Medicines Friday 17 March 2017, Edinburgh, UK Registration has begun for the Institute for Translational Medicine & Therapeutics (ITMAT) in Edinburgh Meeting, which will be held on the theme of ‘Big … Continue reading
Comments Off on Big Data & the Development of New Medicines
Revising the guideline on first-in-human clinical trials
The EMA yesterday published a guideline: Draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products The document can be found here. The consultation period ends 28-Feb-2017.
Comments Off on Revising the guideline on first-in-human clinical trials
Safety & Regulation in Early Clinical Drug Development, 02-Dec-2016
The BAPU (Belgian Association of Phase I Units) board is pleased to invite you to the BAPU Symposium: “Safety & Regulation in Early Clinical Drug Development”, which will take place on Friday December 2, 2016 at the Marriot Hotel in Gent. Please find … Continue reading
Comments Off on Safety & Regulation in Early Clinical Drug Development, 02-Dec-2016
AGAH Meeting, Berlin
AGAH, the German Association for Applied Human Pharmacology, held its 25th Annual Meeting on 21-22 April in Berlin, which focused on the topic “Exploratory drug development in immunological therapy”. The first day’s sessions covered a variety of immunological targets inherently … Continue reading
Comments Off on AGAH Meeting, Berlin
Discount for AHPPI members at ACCP Meeting in Bethesda, MD, Sep-2016
Registration is open for the 2016 Annual Meeting of the American College of Clinical Pharmacology (ACCP). The meeting runs from 25th – 27th September at the Bethesda N Marriott Hotel & Conference Ctr in Bethesda, MD. The title of this year’s … Continue reading
Comments Off on Discount for AHPPI members at ACCP Meeting in Bethesda, MD, Sep-2016
EUFEMED Conference, May 2017, London
Save the date! The European Federation for Exploratory Medicines Development (EUFEMED) has scheduled it’s biennial conference for 17-19 May 2017 in London. The AHPPI will be organising the meeting and members will be entitled to a discounted rate. The programme is … Continue reading
Comments Off on EUFEMED Conference, May 2017, London
Club Phase 1 meeting, Paris
Club Phase 1, a group representing early clinical development stakeholders in France, held their 16th Annual Meeting in Paris on 22nd March. Topics ranged from dealing with immunogenicity to Drug Drug Interactions and a session led by a Biotrial representative … Continue reading
Comments Off on Club Phase 1 meeting, Paris
10 years after TeGenero – link to the Duff Report
After the TeGenero clinical trial 10 years ago, Professor Gordon Duff led an expert review committee and published a report including 22 recommendations. The Duff report (published in December 2006), has been removed from the www.dh.gov.uk site, but can be found at http://webarchive.nationalarchives.gov.uk.
Comments Off on 10 years after TeGenero – link to the Duff Report